WEBINAR: Policy Spotlight: What You Need to Know About the Medicare IPPS Rule
Join the National Marrow Donor Program/Be The Match and the American Society for Blood and Marrow Transplantation (ASBMT) for a 30-minute joint webinar to review the impact of the FY 2018 Inpatient Prospective Payment System proposed rule. Learn more about our efforts to increase reimbursement for donor search and cell acquisition and the autologous/allogeneic ICD-10 PCS coding issue that could have a serious impact on future reimbursement.
||Date: May 31, 2017 12:00 noon - 12:30 p.m. CDT
||Speakers: Susan Leppke, MPH & Alicia Silver, MPP (NMDP/Be The Match) Stephanie Farnia, MPH (ASBMT)
View our analysis and submit a comment. Comments are due by June 13.
MLN Matters: OIG
week, in response to our request, CMS issued a revision to the November MLN Matters guidance that mistakenly
stated that most allogeneic transplants should occur in the outpatient setting. While the revised article did remove the
incorrect sentence around exclusive clinical setting, the revised article could
have gone further to state that allogeneic HCT should be performed in the most
appropriate setting based on clinical judgement.
Medicare Advantage coverage policies have been affected by the MLN Matters
guidance. Together with the ASBMT, we are writing letters to all of the
Medicare Advantage plans that have changed their coverage language to require a
review of allogeneic HCT in the inpatient setting. As always, we will keep you
updated through this enewsletter, but please reach out to our team if you see
patient care affected by revised coverage policies due to the MLN Matters
Joint NMDP/Be The
Match and ASBMT SCD Congressional Briefing
On June 7, we and the American Society of Hematology
(ASH) are co-sponsoring a Congressional briefing on the advancements in sickle cell disease (SCD) research. Speakers include Rep. Bill Foster, Ph.D., as well as SCD experts,
Linda Burns, M.D., and Dan Bauer, M.D., Ph.D. A transplant recipient will also
join the panel to share her experience of struggling with SCD and choosing
transplant as a cure.
Financial Hardship is
Not Limited to Unrelated HCT Patients
we expand our services to related donor transplants, these patients have access
to our patient assistance grants. Learn about the grants and how
one young man benefited.
Forward to a Friend
Please forward this email to others who would benefit from this information. If this email was forwarded to you, we invite you to subscribe.
If you have any questions or need additional information, please contact the Payer Policy Team at PayerPolicy@nmdp.org. All of our resources are available on our website: Network.BeTheMatchClinical.org/Reimbursement.